Skip to content

Cancer · Gynaecological cancers

Endometrial (uterine) cancer — treatment in Lucknow

Cancer of the womb lining is usually found early because it causes bleeding after menopause or between periods. Surgery cures most early cases; medical oncology adds chemotherapy for higher-risk or advanced disease, and molecular classification is increasingly guiding who needs what.

Treatment is shared between medical oncology, surgery and radiation oncology.

Written by Mash Media editorialClinically reviewed by Dr. Harshvardhan Atreya on 1 October 2026Published 1 October 2026

What the diagnosis means

Endometrial cancer arises in the lining of the uterus. Most are endometrioid adenocarcinomas linked to oestrogen exposure (obesity, diabetes, late menopause, no pregnancies); a smaller group of high-grade types (serous, clear cell, carcinosarcoma) behave more aggressively. Diagnosis is by ultrasound and endometrial biopsy; staging is surgical, supported by MRI or CT.

Modern pathology adds a molecular classification — POLE-mutated, mismatch-repair deficient (dMMR), p53-abnormal, or "no specific molecular profile" — which predicts risk of recurrence and response to treatment. Ask whether this has been done on your specimen.

Where medical oncology fits

  • Surgery (removal of uterus, ovaries and tubes, with lymph-node assessment) by a gynaecological oncologist is the main treatment and is curative for most early-stage disease.
  • After surgery, depending on stage, grade and molecular type: no further treatment, radiation (external or vaginal brachytherapy) by the radiation oncologist, chemotherapy, or a combination. Medical oncology provides chemotherapy for high-risk and stage III–IV disease.
  • Advanced or recurrent disease: chemotherapy with immunotherapy (particularly effective for dMMR cancers), immunotherapy combinations, or hormone therapy for low-grade, hormone-receptor-positive cancers — a gentle, tablet-based option for suitable patients.

What to expect

Adjuvant chemotherapy is typically four to six three-weekly cycles; side effects include hair loss, tiredness, nausea, nerve tingling and low blood counts. Immunotherapy adds immune-related effects that are monitored with blood tests. Follow-up examinations continue for several years; vaginal bleeding after treatment always needs review.

Questions to ask

  • What is my stage, grade and molecular type, and what risk group does that put me in?
  • After surgery, do I need radiation, chemotherapy, both, or neither?
  • If the cancer is advanced: is immunotherapy or hormone therapy an option for my type?
  • Should I be tested for Lynch syndrome (if dMMR)?
  • How will treatment affect my weight, diabetes and heart health?

Preparing for your consultation

Bring the biopsy and surgical pathology reports (including molecular results), MRI/CT reports, and a medicine list including hormone treatments. Note diabetes, blood pressure and weight history — they influence treatment choices.

Sources

  1. NCI PDQ — Endometrial Cancer Treatment (Patient)
  2. NHS — Womb (uterus) cancer
  3. National Cancer Grid (India) — treatment guidelines

Related treatments

Patient education on this topic

Gynaecological cancers

Discuss endometrial (uterine) cancer treatment with Dr Harsh Atreya

Our coordinator calls you back to arrange a slot at Medanta Hospital, Lucknow. A request is not a confirmed booking.